Research Progress on Anti-Vascular Endothelial Growth Factor-Induced Retinal Pigment Epithelium Tear
Autor: | He Guiyun, Wei Liping |
---|---|
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Intraocular pressure Retinal pigment epithelium genetic structures business.industry Growth factor medicine.medical_treatment Macular degeneration medicine.disease eye diseases Pathogenesis medicine.anatomical_structure Fibrosis Ophthalmology medicine Tears sense organs Stem cell business |
Zdroj: | International Journal of Ophthalmology & Visual Science. 5:15 |
ISSN: | 2637-384X |
DOI: | 10.11648/j.ijovs.20200501.13 |
Popis: | Various eye diseases can cause retinal pigment epithelium (RPE) tear. RPE tear is common in neovascular age-related macular degeneration (nAMD). The injection of anti-vascular endothelial growth factor (VEGF) increases the risk of PRE tear, the mechanism of which is a sudden change in intraocular pressure during drug injection, vitreous macular traction, destruction of the RPE tight junction barrier and secondary contraction and fibrosis of the choroidal neovascular membrane. The height of pigment epithelial detachment (PED) is an important risk factor for RPE tear in patients with nAMD after injection of anti-VEGF drugs. The diagnosis of RPE tears primarily relies on imaging studies,such as fundus photography、fundus autofluorescence、optical coherence tomography and so on. Regarding treatment, we must first determine whether the patient has a RPE tear, or whether there are risk factors related to the RPE tear, and then perform the corresponding personalized treatment. If possible, consider stem cell transplant alternatives. There is no proven method to prevent RPE tear so far. This article will review and summarize the research progress in the pathogenesis, risk factors, diagnosis, treatment and prevention of RPE tear caused by anti-VEGF drugs, and further improve the understanding of RPE tears,in order to provide reference for clinical work. |
Databáze: | OpenAIRE |
Externí odkaz: |